Asset Finance Funds Aim for Pharma Cash, Partnerships
Executive Summary
Like many of its drug-industry brethren, Bayer Healthcare AG says it's ready to find good homes for the drug candidates it can't develop itself
You may also be interested in...
Flexion Selects First Four Programs And Gets $9 Million From Pfizer Venture Fund
Modeled on Lilly's Chorus unit, Flexion purports to bring candidates to proof-of-concept quicker and cheaper than a Big Pharma typically can.
GSK And Pfizer Join Forces In New HIV-Focused Venture
ViiV Healthcare will market the two companies' combined portfolio of 10 HIV drugs while also taking over a 17-compound R&D operation.
Covance R&D Deal Meshes With Lilly’s “FIPNet” Model
Lilly has deepened its commitment to its fully integrated pharmaceutical network strategy, most recently adding a deal with the contract research organization Covance